PATENT CLAIM ANALYSIS

Application Number: 15910617
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Coronaviruses, vaccines comprising the same, and methods for preventing disease. One embodiment of such includes a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a non-structural protein (nsp)-15, the replicase gene encoding the nsp15 and causes any change, including mutations and/or deletions, that affects the stability or activity of the nsp15.

Claim (Index 3):
The coronavirus of  claim 1 , wherein the coronavirus is a mutation of a wild-type coronavirus.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15328179', '14707356', '11135603', '10714534', '14413385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7613445109582876
- 35 USC 102 Novelty (BERT): 0.5215481337832005
- Combined Prediction Score: 0.7373648732407789
- Mean Citation Score: 308.185418
- Max Citation Score: 333.40042
- Similarity Product: 274.198909735949

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test